日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Ranking distribution reveals opposite shifts in evenness and survival thresholds of phytoplankton under environmental stress

排序分布揭示了环境胁迫下浮游植物均匀度和存活阈值的相反变化

期刊:ISME Journal
影响因子:10
doi:10.1093/ismejo/wrag049
Ye, Sisi; Gao, Li; Chang, Chao; Zhang, Xinyi; Zhou, Yun; Xiao, Man; Yang, Fang; Li, Ming
发表日期：2026
文献求助 收藏

First-line immunotherapy for advanced HER2-negative gastric cancer: differences between Asian and non-Asian patients

晚期HER2阴性胃癌的一线免疫疗法：亚洲患者与非亚洲患者的差异

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2025.0398
Zhao, Chuanhua; Ye, Sisi; Chen, Meng; Qian, Jing; Xu, Jianming
胃癌
肿瘤
肿瘤免疫
HER2
免疫/内分泌
发表日期：2026
文献求助 收藏

Comparative effectiveness of first-line taxane-platinum versus fluorouracil-platinum chemotherapy in advanced esophageal squamous cell carcinoma: a propensity score-matched real-world study

一线紫杉烷-铂类化疗与氟尿嘧啶-铂类化疗治疗晚期食管鳞状细胞癌的疗效比较：一项倾向评分匹配的真实世界研究

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359261436621
Ye, Sisi; Li, Chao; Liu, Rongrui; Zhao, Chuanhua; Li, Juan; Xu, Jianming
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Comparison of the differentially enriched mutations/pathways between stage II and stage IV dMMR/MSI-H colorectal cancer

比较 II 期和 IV 期 dMMR/MSI-H 结直肠癌中差异富集的突变/通路

期刊:Science Progress
影响因子:2.9
doi:10.1177/00368504251412580
Han, Chun; Ye, Sisi; Li, Juan; Qiao, Qian; Bai, Li; Zhang, Tingting
肿瘤
肠癌
肿瘤免疫
多发性骨髓瘤
信号转导
多发性硬化症
发表日期：2026
文献求助 收藏

Integrated single-cell and functional analyses define strategies to enhance dendritic cell immunostimulatory capacity.

整合单细胞和功能分析，制定增强树突状细胞免疫刺激能力的策略。

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-026-04815-6
Li Yuting, Li Huanhuan, Li Chao, Liu Rongrui, Ye Sisi, Li Juan, Zhao Chuanhua, Ma Xiaomin, Cheng Xudong, Xu Jianming
树突状细胞
免疫/内分泌
细胞生物学
树突状细胞
单细胞
发表日期：2026
文献求助 收藏

Treatment strategies for advanced neuroendocrine neoplasms: current status and future prospects

晚期神经内分泌肿瘤的治疗策略：现状与展望

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2024.0507
Ye, Sisi; Li, Juan; Xu, Jianming
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

The Efficacy and Safety of Nivolumab Combined with Nab-Paclitaxel or Oxaliplatin as a First-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer

纳武利尤单抗联合白蛋白紫杉醇或奥沙利铂一线治疗晚期或转移性胃癌和胃食管交界处癌的疗效和安全性

期刊:Journal of Gastrointestinal Cancer
影响因子:1.6
doi:10.1007/s12029-025-01211-1
Li, Juan; Li, Shuman; Zhang, Ying; Ye, Sisi; Liu, Rongrui; Shi, Weiwei
胃癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition

HMGA2通过调控上皮-间质转化促进癌症转移。

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1320887
Ma, Qing; Ye, Sisi; Liu, Hong; Zhao, Yu; Mao, Yan; Zhang, Wei
信号转导
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

The Role of SPEN Mutations as Predictive Biomarkers for Immunotherapy Response in Colorectal Cancer: Insights from a Retrospective Cohort Analysis

SPEN基因突变作为结直肠癌免疫治疗反应预测生物标志物的作用：一项回顾性队列分析的启示

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm14020131
Dong, Yuanmei; Ye, Sisi; Li, Huizi; Li, Juan; Liu, Rongrui; Zhu, Yanyun
肿瘤
肠癌
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

The emerging role and mechanism of HMGA2 in breast cancer

HMGA2在乳腺癌中的新兴作用和机制

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-024-05785-4
Ma, Qing; Ye, Sisi; Liu, Hong; Zhao, Yu; Zhang, Wei
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏